PanGen Biotech Inc. (KOSDAQ:222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,890.00
-115.00 (-2.87%)
At close: Nov 6, 2026

PanGen Biotech Market Cap

PanGen Biotech has a market cap or net worth of 52.57 billion as of November 5, 2026. It is the 31,517th most valuable company in the world and the 1,696th biggest in South Korea. Its market cap has decreased by 34.41% in one year.

Market Cap
52.57B
Enterprise Value
40.53B
Revenue
14.18B
Global Rank
Country Rank
#1,696 South Korea
PE Ratio
50.39

Chart

Chart

Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 52.57B, a decrease of -69.31%. That is a compound annual growth rate of -10.49%.

History

DateMarket Cap% Change
Nov 6, 202652.57B-30.43%
Dec 30, 202575.57B2.79%
Dec 30, 202473.52B0.08%
Dec 28, 202373.46B5.85%
Dec 29, 202269.40B-30.44%
Dec 30, 202199.78B1.96%
Dec 30, 2020 Pro Pro
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Naturalendo Tech65.51B
CTCBIO62.40B
SunBio,Inc.61.68B
ABION60.91B
IMGT Co.,Ltd.57.82B
TegoScience53.72B
KoBioLabs51.46B
Psomagen51.36B
Market Cap Rankings